Aeschlimann FA, Barra L, Alsolaimani R, et al. Presentation and disease course of childhood-onset versus adult-onset takayasu arteritis. Arthritis Rheumatol. 2019;71:315–23.

Article  PubMed  Google Scholar 

Aeschlimann FA, Yeung RSM, Laxer RM. An update on childhood-onset Takayasu arteritis. Front Pediatr. 2022;10: 872313.

Article  PubMed  PubMed Central  Google Scholar 

Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017;46:e197–203.

Article  PubMed  Google Scholar 

Mossberg M, Segelmark M, Kahn R, Englund M, Mohammad A. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Scand J Rheumatol. 2018;47:295–302.

Article  CAS  PubMed  Google Scholar 

Danda D, Goel R, Joseph G, et al. Clinical course of 602 patients with Takayasu’s arteritis: comparison between childhood-onset versus adult onset disease. Rheumatology (Oxford). 2021;60:2246–55.

Article  CAS  PubMed  Google Scholar 

Hassold N, Dusser P, Laurent A, et al. Clinical spectrum and outcome of Takayasu’s arteritis in children. Jt Bone Spine. 2024;91: 105735.

Article  Google Scholar 

Arita Y, Ishibashi T, Nakaoka Y. Current immunosuppressive treatment for Takayasu arteritis. Circ J. 2024;88:1605–9.

Article  PubMed  Google Scholar 

Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73:1349–65.

Article  PubMed  Google Scholar 

Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79:19–30.

Article  PubMed  Google Scholar 

Members WC, Isselbacher EM, Preventza O, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;80:e223–393.

Google Scholar 

Misra DP, Singh K, Rathore U, et al. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: a systematic review and meta-analysis. Autoimmun Rev. 2023;22: 103275.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.

Article  PubMed  Google Scholar 

Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. 2021. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 4 May 2025.

Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. Joanna Briggs Institute; 2020. pp. 217–69.

Aeschlimann FA, Eng SWM, Sheikh S, et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther. 2017;19:255.

Article  PubMed  PubMed Central  Google Scholar 

Aeschlimann FA, Grosse-Wortmann L, Benseler SM, Laxer RM, Hebert D, Yeung RS. Arterial dissection in childhood Takayasu arteritis: not as rare as thought. Pediatr Rheumatol Online J. 2016;14:56.

Article  PubMed  PubMed Central  Google Scholar 

Almasi S, Asadian S, Rezaeian N. Anterior ST-segment elevation myocardial infarction in a teenager: a diagnostic dilemma. JACC Case Rep. 2024;29: 102279.

Article  PubMed  PubMed Central  Google Scholar 

Asano T, Sato S, Temmoku J, et al. Effectiveness of tocilizumab in juvenile patients with refractory Takayasu arteritis: two case reports. Medicine (Baltimore). 2020;99: e18890.

Article  PubMed  PubMed Central  Google Scholar 

Batu ED, Sönmez HE, Hazırolan T, Özaltın F, Bilginer Y, Özen S. Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature. Semin Arthritis Rheum. 2017;46:529–35.

Article  CAS  PubMed  Google Scholar 

Baykal G, Sözeri B. Concurrent pyoderma gangrenosum and Takayasu arteritis in an infant: diagnostic challenges and treatment considerations. Turk J Pediatr. 2024;66:116–23.

Article  PubMed  Google Scholar 

Bikouli EDC, Vazeou A, Xatzipsalti M, Servos G, Delis D, Maritsi DN. Blau Syndrome complicated by atypical type IIa Takayasu arteritis. J Child Sci. 2021;11:e313–6.

Article  Google Scholar 

Borhani Haghighi A, Mahmoudi Nezhad GS, Amoozgar H. Lifesaving vertebral artery stenting in a child with Takayasu arteritis. Iran J Pediatr. 2015;25: e262.

Article  PubMed  PubMed Central  Google Scholar 

Bracaglia C, Buonuomo PS, Campana A, Insalaco A, Nicolai R, Cortis E. Early diagnosis of pediatric Takayasu arteritis (TA) not fullfiling the ACR criteria. Clin Exp Rheumatol. 2009;27:S140.

CAS  PubMed  Google Scholar 

Bravo Mancheño B, Perin F, Guez Vázquez Del Rey Mdel M, García Sánchez A, Alcázar Romero PP. Successful tocilizumab treatment in a child with refractory Takayasu arteritis. Pediatrics. 2012;130:e1720–4.

Buonuomo PS, Bracaglia C, Campana A, et al. Infliximab therapy in pediatric Takayasu’s arteritis: report of two cases. Rheumatol Int. 2011;31:93–5.

Article  PubMed  Google Scholar 

Çakar N, Özçakar ZB, Soy D, et al. Renal involvement in childhood vasculitis. Nephron Clin Pract. 2008;108:c202–6.

Article  PubMed  Google Scholar 

Cakar N, Yalcinkaya F, Duzova A, et al. Takayasu arteritis in children. J Rheumatol. 2008;35:913–9.

PubMed  Google Scholar 

Cañas CA, Cañas F, Izquierdo JH, et al. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis. J Clin Rheumatol. 2014;20:125–9.

Article  PubMed  Google Scholar 

Choe YJ, Blatt DB, Yalcindag A, Geffert SF, Bobenchik AM, Michelow IC. Cryptococcus albidus fungemia in an immunosuppressed child: case report and systematic literature review. J Pediatr Infect Dis Soc. 2020;9:100–5.

Google Scholar 

Clemente G, Hilário MO, Len C, et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu’s arteritis: clinical and angiographic features. Rev Bras Reumatol Engl Ed. 2016;56:145–51.

Article  PubMed  Google Scholar 

Clemente G, Pereira RMR, Aikawa N, et al. Is positron emission tomography/magnetic resonance imaging a reliable tool for detecting vascular activity in treated childhood-onset Takayasu’s arteritis? A multicentre study. Rheumatology (Oxford). 2022;61:554–62.

Article  CAS  PubMed  Google Scholar 

De Guerra VC, Hashmi H, Kramer B, et al. A case report of Takayasu’s arteritis and ulcerative colitis in a pediatric patient with chronic recurrent multifocal osteomyelitis successfully treated with infliximab: diagnostic clues in disease associations and immune dysregulation. Case Rep Rheumatol. 2019;2019:8157969.

PubMed  PubMed Central  Google Scholar 

Decker P, Olivier P, Risse J, Zuily S, Wahl D. Tocilizumab and refractory Takayasu disease: four case reports and systematic review. Autoimmun Rev. 2018;17:353–60.

Article  CAS  PubMed  Google Scholar 

Della Rossa A, Tavoni A, Merlini G, et al. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? Rheumatology (Oxford). 2005;44:1074–5.

Article  CAS  PubMed  Google Scholar 

Desai R, Barr B, Vesely M, Aktay R, Forbess L. STEMI following in-stent restenosis in coronary Takayasu arteritis with pyoderma gangrenosum in a teenaged athlete. JACC Case Rep. 2024;29: 102487.

Article  PubMed  PubMed Central  Google Scholar 

El-Matary W, Persad R. Takayasu’s aortitis and infliximab. J Pediatr. 2009;155:151.

Article  PubMed  Google Scholar 

Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;17:36.